Erimycin For Suspension

Erimycin For Suspension

erythromycin

Manufacturer:

Siam Bheasach

Distributor:

Siam Pharmaceutical

Marketer:

Siam Pharmaceutical
Concise Prescribing Info
Contents
Erythromycin
Indications/Uses
Susceptible infections eg, URTI, lower resp tract & skin infection of mild to moderate severity; erythrasma; acute pelvic inflammatory disease (as alternative to penicillin-allergic patients); non-gonococcal urethritis (as alternative to azithromycin or doxycycline); uncomplicated urethral, endocervical or rectal infections (as alternative to azithromycin or tetracyclines); chlamydial urogenital infections during pregnancy & pneumonia or ophth neonatorum in infants; diphtheria as adjunct to antitoxin; pertussis; Legionnaire disease; intestinal amebiasis. Alternative to penicillin-allergic patients in prevention of initial & recurrent attacks of rheumatic fever.
Dosage/Direction for Use
Adult 400 mg every 6 hr. May be increased to max dose of 4 g daily. Administer at least 10 days for Strep infections. Prophylaxis of recurrent rheumatic fever 400 mg bid. Non-gonococcal urethritis 800 mg qid for 7 days. Chlamydial infection 800 mg qid for 7 days or 400 mg qid for 14 days if w/ GI intolerance. Pertussis 40-50 mg/kg daily in 4 divided doses for 5-14 days. Legionnaire disease 1.6-4 g daily in divided doses. Intestinal amebiasis 400 mg qid for 10-14 days. Childn 30-50 mg/kg daily in 4 divided doses every 6 hr. Max: 3.2 g daily. Administer at least 10 days for Strep infections. Community-acquired pneumonia in childn & infant >3 mth w/ presumed mild atypical infection (Mycoplasma pneumoniae, Chlamydia pneumoniae, Chlamydia trachomatis) or step-down therapy 10 mg/kg every 6 hr. Chlamydial infection 50 mg/kg daily in 4 divided doses for 14 days. Pertussis 40-50 mg/kg daily in 4 divided doses for 5-14 days. Intestinal amebiasis 30-50 mg/kg daily in 4 divided doses for 10-14 days.
Administration
May be taken with or without food: May be taken w/ food to decrease GI upset. Do not give w/ milk or acidic beverages.
Contraindications
Hypersensitivity to erythromycin or any macrolide antibiotics. Concomitant use w/ pimozide, cisapride, ergotamine or dihydroergotamine, terfenadine, astemizole, lovastatin or simvastatin.
Special Precautions
QTc prolongation & ventricular arrhythmias, including Torsades de Pointes. Superinfection w/ prolonged use including Clostridium difficile-associated diarrhea (CDAD) (>2 mth post-antibiotic treatment) & pseudomembranous colitis. May aggravate muscle weakness in patients w/ myasthenia gravis. Avoid use in patients w/ prolonged QT interval, uncorrected hypokalemia or hypomagnesemia or clinically significant bradycardia. Concurrent use of class IA (ie, quinidine, procainamide) or class III (ie, amiodarone, dofetilide, sotalol) antiarrhythmics. Hepatic impairment including increased liver enzymes & hepatocellular &/or cholestatic hepatitis w/ or w/o jaundice. Pregnancy & lactation. Infantile hypertrophic pyloric stenosis (IHPS) in infants.
Adverse Reactions
QTc prolongation, torsades de pointes, ventricular arrhythmia & tachycardia; convulsions; erythema multiforme, SJS, TEN, urticaria, skin reaction, photosensitivity, pruritus, rash; abdominal pain/discomfort, anorexia, diarrhea, nausea, pancreatitis, pseudomembranous colitis/CDAD, vomiting, IHPS, oral candidiasis; abnormal LFTs, hepatocellular &/or cholestatic hepatitis (w/ or w/o jaundice); weakness; interstitial nephritis; hearing loss; allergic & hypersensitivity reactions, anaphylaxis.
Drug Interactions
Increased plasma conc w/ antifungal agent ie, fluconazole, ketoconazole, itraconazole. Potentially serious adverse CV effects w/ astemizole & terfenadine. Increased serum conc of diltiazem or verapamil, digoxin, carbamazepine & cyclosporine. Increased plasma conc of cisapride. Induced ischemic reactions, peripheral vasospasm & dysesthesia w/ ergot alkaloids. Decreased metabolism of benzodiazepines. Decreased clearance, elevated serum conc & prolong t½ of theophylline. Increased anticoagulant effect of warfarin.
MIMS Class
Macrolides
ATC Classification
J01FA01 - erythromycin ; Belongs to the class of macrolides. Used in the systemic treatment of infections.
Presentation/Packing
Form
Erimycin For Suspension oral susp 200 mg/5 mL
Packing/Price
60 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in